The neurotoxic effects of ochratoxin-A are reduced by protein binding but are not affected by l-phenylalanine

Toxicology and Applied Pharmacology

Volumn 146, Issue 2, 1997, Pages 173-179

  Bruinink, A ^a   Sidler, C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OCHRATOXIN; PHENYLALANINE;

ANIMAL CELL; ARTICLE; BRAIN CELL; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; NEUROTOXICITY; NONHUMAN; PROTEIN BINDING; RETINA NERVE CELL;

EID: 0030771037     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8229     Document Type: Article

References (35)

1. F. M. Barker, 1992, Canthaxanthin and the eye, a critical ocular toxicological review, Proceedings of the 1992 European Meeting of the Toxicology Forum, 478, 500.
2. Braunberg R. C., Gantt O., Barton C., Friedman L. In vitro effects of the nephrotoxins ochratoxin A and citrinin upon biochemical function of porcine kidney. Arch. Environ. Contam. Toxicol. 22:1992;464-470.
3. Brown M. H., Szczech G. M., Purmalis B. P. Teratogenic and toxic effects of ochratoxin A in rats. Toxicol. Appl. Pharmacol. 37:1976;331-338.
4. Bruinink A. Serum-free monolayer cultures of embryonic chick brain and retina: Immunoassays of developmental markers, mathematical data analysis and establishment of optimal culture conditions. The Brain in Bits and Pieces. 1992a;MTC Verlag, Zollikon. p. 23-50.
5. Bruinink A. Oculotoxicity in vitro. Jolles G. In Vitro Methods in Toxicology. 1992b;353-366 Academic Press, London.
6. Bruinink A., Birchler F. Effects of cisplatin and ORG.2766 in chick embryonic cell cultures. Arch. Toxicol. 67:1993;325-329.
7. Bruinink A., Cohn W., Sidler C., Grun, Weiser H. Effects of HDL and HDL associated canthasxanthin in vitro: Tissue specific on HDL and induction of crystal formation by canthaxanthin. Experientia. 50:1994;A47.
8. Bruinink A., Rásonyi T., Sidler C. Reduction of ochratoxin A toxicity by heat induced epimerization. In vitro effects of ochratoxins on embryonic chick meningeal and other cell cultures. Toxicology. 1997.
9. Bruinink A., Reiser P. Ontogeny of MAP2 and GFAP antigens in primary cultures of embryonic chick brain: Effect of substratum, oxygen tension, serum and ARA-C. Int. J. Dev. Neurosci. 9:1991;269-279.
10. Bruinink A., Reiser P., Müller M., Gähwiler B. H., Zbinden G. Neurotoxic effects of bismuth in vitro. Toxic. in Vitro. 6:1992;285-293.
11. Bruinink A., Sidler C., Birchler F. Neurotrophic effects of transferrin on embryonic chick brain and neural retina cell cultures. Int. J. Dev. Neurosci. 14:1996;785-795.
12. Bruinink A., Zimmermann G., Riesen F. Neurotoxic effects of chloroquine in vitro. Arch. Toxicol. 65:1991;480-484.
13. Creppy E. E., Kern D., Steyn P. S., Vleggaar R., Röschenthaler R., Dirheimer G. Comparative study of the effects of ochratoxin A analoques on yeast phenylalanyl-tRNA synthetase and on the growth and protein synthesis of hepatoma cells. Tox. Lett. 19:1983;217-224.
14. Creppy E. E., Röschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Fd. Chem. Toxic. 22:1984;883-886.
15. Creppy E. E., Chakor K., Fisher M. J., Dirheimer G. The mycotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo. Arch. Toxicol. 64:1990;279-284.
16. Dirheimer G., Creppy E. E. Mechanism of action of ochratoxin A. IARC Sci. Publ. 115:1991;171-186.
17. Föllmann W., Hillebrand I. E., Creppy E. E., Bolt H. M. Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch. Toxicol. 69:1995;280-286.
18. Fukui Y., Hoshino K., Kameyama Y., Yasui T., Toda C., Nagano H. Placental transfer of ochratoxin A and its cytotoxic effect on the mouse embryonic brain. Fd. Chem. Toxic. 25:1987;17-24.
19. Hagelberg S., Hult K., Fuchs R. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9:1989;91-96.
20. Hald B. Ochratoxin A in human blood in European countries. IARC Sci. Publ. 115:1991;159-164.
21. Hamburger V., Hamilton H. L. A series of normal stages in the development of the chick embryo. J. Morphol. 88:1951;49-92.
22. Jonsyn F. E., Maxwell S. M., Hendrickse R. G. Human fetal exposure to ochratoxin A and aflatoxins. Ann. Trop. Paediatr. 15:1995;3-9.
23. Marquardt R. R., Frohlich A. A. A review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 70:1992;3968-3988.
24. Mayura K., Parker R., Berndt W. O., Phillps T. D. Ochratoxin A-induced teratogensesis in rats: partial protection by phenylalanine. Appl. Environ. Microbiol. 48:1984;1186-1188.
25. Micco C., Miraglia M., Corneli S., Ambruzzi A. Evaluation of ochratoxin A level in human milk in Italy. Food Addit. Contam. 12:1995;351-354.
26. Miki T., Fukui Y., Uemura N., Takeuchi Y. Regional difference in the neurotoxicity of ochratoxin A on the developing cerebral cortex in mice. Dev. Brain Res. 82:1994;259-264.
27. Moroi K., Suzuki S., Kuga T., Yamazaki M., Kanisawa M. Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital. Toxicol. Lett. 25:1985;1-5.
28. Müller J. P., Bruinink A. Neurotoxic effects of aluminium on embryonic chick brain cultures. Acta Neuropathol. 88:1994;359-366.
29. Rahimtula A. D., Béréziat J. C., Bussaccini-Grot V., Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37:1988;4469-4477.
30. Rotter R. G., Marquardt R. R., Frohlich A. A. Ochratoxin A toxicity in growing chicks: Effect of supplemental dietary phenylalanine. Nutr. Rep. Int. 40:1989;1091-1100.
31. Shirai S. Developmental mechanisms of congenital eye abnormalities. Nippon Ganka Gakkai Zasshi. 95:1991;1206-1237.
32. Stojkovic R., Hult K., Gamulin S., Plestina R. High affinity binding of ochratoxin A to plasma constituents. Biochem. Int. 9:1984;33-38.
33. Tamaru M., Hirata Y., Matsutani T. Neurochemical effects of prenatal treatment with ochratoxin A on fetal and adult mouse brain. Neurochem. Res. 13:1988;1139-1147.
34. Terse P. S., Madhyastha M. S., Zurovac O., Stringfellow D., Marquardt R. R., Kemppainen B. W. Comparison of in vitro and in vivo biological activity of mycotoxins. Toxicon. 31:1993;913-919.
35. Ueno Y., Umemori K., Niimi E., Tanuma S., Nagata S., Sugamata M., Ihara T., Sekijima M., Kawai K., Uneno I., Tashiro F. Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukemia cells. Nat. Toxins. 3:1995;129-137.